New strategies in dopaminergic therapy of Parkinson's disease: the use of a controlled-release formulation.
Duvoisin
R C
RC
Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick 08903-0019.
D003692:Delayed-Action Preparations; D015259:Dopamine Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*
D003692:Delayed-Action Preparations; D015259:Dopamine Agents